Galecto appoints former Blueprint Medicines executives as COO and CMO
Source: SeekingAlpha
2026-01-06 09:29:09 ET
More on Galecto
- Galecto, Inc. (GLTO) M&A Call - Slideshow
- Seeking Alpha’s Quant Rating on Galecto
- Historical earnings data for Galecto
- Financial information for Galecto
Read the full article on Seeking Alpha
For further details see:
Galecto appoints former Blueprint Medicines executives as COO and CMO
Galecto Inc.
NASDAQ: GLTO
GLTO Trading
-8.08% G/L:
$27.75 Last:
51,514 Volume:
$28.31 Open:
GLTO Latest News
March 02, 2026 08:00:00 am
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference
February 12, 2026 04:01:00 pm
Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million
February 10, 2026 10:42:03 pm
Galecto Announces Pricing of $275 Million Underwritten Public Offering
GLTO Stock Data
$34,694,752
1,428,307
27.85%
11
N/A
Biotechnology & Life Sciences
Healthcare
DK
Boston
